Last checked at 19 Apr 2021 07:00
19 April 2021
Benchmark Holdings plc
("Benchmark" or the "Company")
Notice of Q2 and Interim Results
Webcast for analysts and institutional investors
Equity Development webcast for retail investors
Benchmark Holdings plc (AIM: BMK), the aquaculture health, advanced nutrition, and genetics business, will announce its Q2 and Interim results for the three and six month periods ended 31 March 2021, on Tuesday 18 May 2021.
Webcast for analysts and institutional investors at 9am UK time
Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a webcast for analysts and institutional investors on that day at 09:00am UK time. To register your interest, please contact benchmark@mhpc.com.
Equity Development webcast for retail investors at 12:30pm UK time
Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a separate webcast for retail investors and wealth managers at 12.30pm UK time. The webcast is open to all existing and potential shareholders. Questions can be submitted during the presentation which will be addressed at the end.
To register please visit: https://www.equitydevelopment.co.uk/news-and-events/benchmark-holdings-interim-results-investor-presentation-18th-may-2021.
Enquiries
|
|
About Benchmark
Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability.
We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.
Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), diets and probiotics and sea lice treatments. Find out more at www.benchmarkplc.com